ArriVent BioPharma (AVBP) Earnings Date, Estimates & Call Transcripts → [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad) Free AVBP Stock Alerts $19.41 -0.05 (-0.26%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 8) -$0.70 Beat By $0.14 Consensus EPS (May. 8) -$0.84 Get ArriVent BioPharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for AVBP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAVBP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVBP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the Markets“This will be one of the biggest revolutions ever.” - NVIDIA CEONVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it.A new breakthrough tech could add up to $20 trillion to the U.S. economy. ArriVent BioPharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($1.25)($1.25)($1.25)Q2 20242($0.75)($0.64)($0.70)Q3 20242($1.22)($0.67)($0.95)Q4 20242($1.21)($0.70)($0.96)FY 20247($4.43)($3.26)($3.85)Q1 20251($0.73)($0.73)($0.73)Q2 20251($0.76)($0.76)($0.76)Q3 20251($0.79)($0.79)($0.79)Q4 20251($0.82)($0.82)($0.82)FY 20254($3.10)($3.10)($3.10)AVBP Earnings Date and InformationArriVent BioPharma last released its quarterly earnings results on May 8th, 2024. The reported ($0.70) EPS for the quarter, beating analysts' consensus estimates of ($0.84) by $0.14. ArriVent BioPharma has generated $0.00 earnings per share over the last year. Earnings for ArriVent BioPharma are expected to decrease in the coming year, from ($3.07) to ($3.13) per share. ArriVent BioPharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More ArriVent BioPharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024(Estimated)------- 5/8/2024Q1 2024($0.84)($0.70)+$0.14($0.70)-- ArriVent BioPharma Earnings - Frequently Asked Questions When is ArriVent BioPharma's earnings date? ArriVent BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on AVBP's earnings history. Did ArriVent BioPharma beat their earnings estimates last quarter? In the previous quarter, ArriVent BioPharma (NASDAQ:AVBP) reported ($0.70) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.84) by $0.14. Learn more on analysts' earnings estimate vs. AVBP's actual earnings. How much profit does ArriVent BioPharma generate each year? ArriVent BioPharma (NASDAQ:AVBP) has a recorded net income of -$69.33 million. AVBP has generated $0.00 earnings per share over the last four quarters. What is ArriVent BioPharma's EPS forecast for next year? ArriVent BioPharma's earnings are expected to decrease from ($3.07) per share to ($3.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Dianthus Therapeutics Earnings Harrow Earnings Arbutus Biopharma Earnings Calliditas Therapeutics AB (publ) Earnings Zymeworks Earnings Pharming Group Earnings Mineralys Therapeutics Earnings Phathom Pharmaceuticals Earnings ORIC Pharmaceuticals Earnings Nuvation Bio Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:AVBP) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyNvidia is about to pass AppleWeiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
